
Due to extensive distribution of pathogen resistance to available pharmaceuticals and serious problems in the treatment of various infections and tumor diseases, the necessity of new antibiotics is urgent. The basic methodological approaches to chemical synthesis of antibiotics and screening of new antibiotics among natural products, mainly among microbial secondary metabolites, are considered in the review. Since the natural compounds are very much diverse, screening of such substances gives a good opportunity to discover antibiotics of various chemical structure and mechanism of action. Such an approach followed by chemical or biological transformation, is capable of providing the health care with new effective pharmaceuticals. The review is mainly concentrated on screening of natural products and methodological problems, such as: isolation of microbial producers from the habitats, cultivation of microorganisms producing appropriate substances, isolation and chemical characterization of microbial metabolites, identification of the biological activity of the metabolites. The main attention is paid to the problems of microbial secondary metabolism and design of new models for screening biologically active compounds. The last achievements in the field of antibiotics and most perspective approaches to future investigations are discussed. The main methodological approach to isolation and cultivation of the producers remains actual and needs constant improvement. The increase of the screening efficiency can be achieved by more rapid chemical identification of antibiotics and design of new screening models based on the biological activity detection.
sterol biosynthesis inhibitors, antitumors, antimicrobials, miniaturization, producer cultivation, antivirals, Drug Discovery, RC254-282, secondary metabolism, Bacteriological Techniques, Biological Products, Bacteria, antibiotic recovery and identification, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, new antibiotics, microbial models for antibiotic screening, Anti-Bacterial Agents, Culture Media, High-Throughput Screening Assays, Batch Cell Culture Techniques, microbial test-systems, targets, antibiotic screening, antifungals, Genome, Bacterial
sterol biosynthesis inhibitors, antitumors, antimicrobials, miniaturization, producer cultivation, antivirals, Drug Discovery, RC254-282, secondary metabolism, Bacteriological Techniques, Biological Products, Bacteria, antibiotic recovery and identification, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, new antibiotics, microbial models for antibiotic screening, Anti-Bacterial Agents, Culture Media, High-Throughput Screening Assays, Batch Cell Culture Techniques, microbial test-systems, targets, antibiotic screening, antifungals, Genome, Bacterial
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
